{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Nyxoah SA"},"Symbol":{"label":"Symbol","value":"NYXH"},"Address":{"label":"Address","value":"RUE EDOUARD BELIN 12, MONT-SAINT GUIBERT, 1435, Belgium"},"Phone":{"label":"Phone","value":"+32 10459075"},"Industry":{"label":"Industry","value":"Medical/Dental Instruments"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Europe"},"CompanyDescription":{"label":"Company Description","value":"Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke."},"CompanyUrl":{"label":"Company Url","value":"https://www.nyxoah.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Bruno Onkelinx","title":"Chief Technology Officer"},{"name":"Jeyakumar Subbaroyan","title":"Chief Clinical Officer"},{"name":"Maurits S. Boon","title":"Chief Medical Officer"},{"name":"Olivier Taelman","title":"Chief Executive Officer & Executive Director"},{"name":"Roi Tsukran","title":"Director-Engineering, Research & Development"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}